10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Ral GTPases promote breast cancer metastasis by controlling biogenesis and organ targeting of exosomes

      research-article
      1 , 2 , 3 , 1 , 2 , 3 , 1 , 2 , 3 , 1 , 2 , 3 , 1 , 2 , 3 , 1 , 2 , 3 , 1 , 2 , 3 , 4 , 2 , 3 , 5 , 6 , 1 , 2 , 3 , 7 , 8 , 9 , 10 , 11 , 12 , 1 , 2 , 3 , 13 , 13 , 14 , 15 , 16 , 15 , 16 , 2 , 3 , 5 , 17 , 11 , 12 , 4 , 8 , 1 , 2 , 3 , 1 , 2 , 3 , , 1 , 2 , 3 , 18 ,
      ,
      eLife
      eLife Sciences Publications, Ltd
      exosome, Ral GTPase, pre-metastatic niche, Human, Mouse, Zebrafish

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Cancer extracellular vesicles (EVs) shuttle at distance and fertilize pre-metastatic niches facilitating subsequent seeding by tumor cells. However, the link between EV secretion mechanisms and their capacity to form pre-metastatic niches remains obscure. Using mouse models, we show that GTPases of the Ral family control, through the phospholipase D1, multi-vesicular bodies homeostasis and tune the biogenesis and secretion of pro-metastatic EVs. Importantly, EVs from RalA or RalB depleted cells have limited organotropic capacities in vivoand are less efficient in promoting metastasis. RalA and RalB reduce the EV levels of the adhesion molecule MCAM/CD146, which favors EV-mediated metastasis by allowing EVs targeting to the lungs. Finally, RalA, RalB, and MCAM/CD146, are factors of poor prognosis in breast cancer patients. Altogether, our study identifies RalGTPases as central molecules linking the mechanisms of EVs secretion and cargo loading to their capacity to disseminate and induce pre-metastatic niches in a CD146-dependent manner.

          Related collections

          Most cited references74

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

          In comparative high-throughput sequencing assays, a fundamental task is the analysis of count data, such as read counts per gene in RNA-seq, for evidence of systematic changes across experimental conditions. Small replicate numbers, discreteness, large dynamic range and the presence of outliers require a suitable statistical approach. We present DESeq2, a method for differential analysis of count data, using shrinkage estimation for dispersions and fold changes to improve stability and interpretability of estimates. This enables a more quantitative analysis focused on the strength rather than the mere presence of differential expression. The DESeq2 package is available at http://www.bioconductor.org/packages/release/bioc/html/DESeq2.html. Electronic supplementary material The online version of this article (doi:10.1186/s13059-014-0550-8) contains supplementary material, which is available to authorized users.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets

            Abstract Proteins and their functional interactions form the backbone of the cellular machinery. Their connectivity network needs to be considered for the full understanding of biological phenomena, but the available information on protein–protein associations is incomplete and exhibits varying levels of annotation granularity and reliability. The STRING database aims to collect, score and integrate all publicly available sources of protein–protein interaction information, and to complement these with computational predictions. Its goal is to achieve a comprehensive and objective global network, including direct (physical) as well as indirect (functional) interactions. The latest version of STRING (11.0) more than doubles the number of organisms it covers, to 5090. The most important new feature is an option to upload entire, genome-wide datasets as input, allowing users to visualize subsets as interaction networks and to perform gene-set enrichment analysis on the entire input. For the enrichment analysis, STRING implements well-known classification systems such as Gene Ontology and KEGG, but also offers additional, new classification systems based on high-throughput text-mining as well as on a hierarchical clustering of the association network itself. The STRING resource is available online at https://string-db.org/.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              HISAT: a fast spliced aligner with low memory requirements.

              HISAT (hierarchical indexing for spliced alignment of transcripts) is a highly efficient system for aligning reads from RNA sequencing experiments. HISAT uses an indexing scheme based on the Burrows-Wheeler transform and the Ferragina-Manzini (FM) index, employing two types of indexes for alignment: a whole-genome FM index to anchor each alignment and numerous local FM indexes for very rapid extensions of these alignments. HISAT's hierarchical index for the human genome contains 48,000 local FM indexes, each representing a genomic region of ∼64,000 bp. Tests on real and simulated data sets showed that HISAT is the fastest system currently available, with equal or better accuracy than any other method. Despite its large number of indexes, HISAT requires only 4.3 gigabytes of memory. HISAT supports genomes of any size, including those larger than 4 billion bases.
                Bookmark

                Author and article information

                Contributors
                Role: Senior Editor
                Role: Reviewing Editor
                Journal
                eLife
                Elife
                eLife
                eLife
                eLife Sciences Publications, Ltd
                2050-084X
                06 January 2021
                2021
                : 10
                : e61539
                Affiliations
                [1 ]INSERM UMR_S1109, Tumor Biomechanics StrasbourgFrance
                [2 ]Université de Strasbourg StrasbourgFrance
                [3 ]Fédération de Médecine Translationnelle de Strasbourg (FMTS) StrasbourgFrance
                [4 ]Laboratoire de Spectrométrie de Masse BioOrganique (LSMBO), IPHC UMR 7178, CNRS, Université de Strasbourg StrasbourgFrance
                [5 ]INSERM UMR_S1109, Genomax StrasbourgFrance
                [6 ]CNRS, UMR 7245 MCAM, Muséum National d’Histoire Naturelle de Paris ParisFrance
                [7 ]Université de Bordeaux, CNRS, Laboratoire de Biogenèse Membranaire, UMR 5200 Villenave d'OrnonFrance
                [8 ]Centre National de la Recherche Scientifique, Université de Strasbourg, Institut des Neurosciences Cellulaires et Intégratives StrasbourgFrance
                [9 ]Plateforme Imagerie In Vitro, CNRS UPS 3156 StrasbourgFrance
                [10 ]IGBMC Imaging Center CNRS (UMR7104)/ INSERM (U1258)/ Université de Strasbourg IllkirchFrance
                [11 ]Team SOAP, CRCINA, INSERM, CNRS, Université de Nantes, Université d’Angers NantesFrance
                [12 ]Integrated Center for Oncology, ICO St-HerblainFrance
                [13 ]Nanotranslational laboratory, Institut de Cancérologie Strasbourg Europe StrasbourgFrance
                [14 ]Équipe de synthèse pour l’analyse (SynPA), Institut Pluridisciplinaire Hubert Curien (IPHC), UMR7178, CNRS/Université de Strasbourg StrasbourgFrance
                [15 ]Vincent's Clinical School, Faculty of Medicine, University of New South Wales SydneyAustralia
                [16 ]The Kinghorn Cancer Centre, Garvan Institute of Medical Research SydneyAustralia
                [17 ]C2VN, INSERM 1263, Inrae 1260, Aix-Marseille Université MarseilleFrance
                [18 ]CNRS SNC5055 StrasbourgFrance
                Stanford University School of Medicine United States
                Fox Chase Cancer Center United States
                Fox Chase Cancer Center United States
                United States
                Author notes
                [†]

                These authors contributed equally to this work.

                Author information
                https://orcid.org/0000-0002-5715-4559
                https://orcid.org/0000-0003-0815-842X
                https://orcid.org/0000-0003-0505-6487
                https://orcid.org/0000-0003-1195-753X
                https://orcid.org/0000-0003-3590-9874
                https://orcid.org/0000-0003-4680-3012
                https://orcid.org/0000-0002-6252-4323
                http://orcid.org/0000-0002-1204-9296
                https://orcid.org/0000-0001-6372-1647
                https://orcid.org/0000-0001-9364-1621
                https://orcid.org/0000-0002-7985-9007
                https://orcid.org/0000-0002-0079-319X
                https://orcid.org/0000-0001-9130-9174
                https://orcid.org/0000-0003-2842-8116
                https://orcid.org/0000-0002-1254-2814
                Article
                61539
                10.7554/eLife.61539
                7822591
                33404012
                edc0fbc8-9d8a-4002-996f-623b0e33096b
                © 2021, Ghoroghi et al

                This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

                History
                : 28 July 2020
                : 05 January 2021
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/501100006364, Institut National Du Cancer;
                Award ID: PLBIO19-291
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/501100004099, Ligue Contre le Cancer;
                Award Recipient :
                Funded by: Canceropôle Grand Est;
                Award ID: Exosomics
                Award Recipient :
                Funded by: Plan Cancer;
                Award ID: Vesmatic
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/100004337, Roche;
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/501100001665, Agence Nationale de la Recherche;
                Award ID: ANR-10-INBS-08-03
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/501100001665, Agence Nationale de la Recherche;
                Award ID: ANR-19-CE44-0019
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/501100001665, Agence Nationale de la Recherche;
                Award ID: ANR-11-INBS- 0010
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/100007391, Association pour la Recherche sur le Cancer;
                Award Recipient :
                Funded by: French ministry of Science;
                Award Recipient :
                Funded by: Suttons;
                Award Recipient :
                Funded by: Sydney catalyst;
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/501100000925, NHMRC;
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/501100001102, Cancer Council NSW;
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/100011711, Pancreatic Cancer Action;
                Award Recipient :
                Funded by: Pancreatic cancer resource;
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/501100003768, University of Strasbourg;
                Award Recipient :
                Funded by: Region Est;
                Award ID: Exosomics
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/501100001677, Inserm;
                Award Recipient :
                The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
                Categories
                Research Article
                Cancer Biology
                Cell Biology
                Custom metadata
                A combination of animal models reveal how the molecular mechanisms of exosome secretion (RalA/B-dependent) are linked to their cargo content and their function in breast cancer pre-metastatic niche formation.

                Life sciences
                exosome,ral gtpase,pre-metastatic niche,human,mouse,zebrafish
                Life sciences
                exosome, ral gtpase, pre-metastatic niche, human, mouse, zebrafish

                Comments

                Comment on this article